Maydelis Milo Alvarez

Maydelis Milo Alvarez

Auto-generated profile, based on publicly available information

Maydelis Milo Alvarez


Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 September 2025 in Bionatura Journal
Verified
Journal Article
Open access
MGMarlon Carbonell Gonzalez
Marlon Carbonell Gonzalez
MAMaydelis Milo Alvarez
Maydelis Milo Alvarez
DRDeborah Cabrera Rodríguez
Deborah Cabrera Rodríguez
MWMai Lyng Yon Wong
Mai Lyng Yon Wong
LELhianella Ramos Escobedo
Lhianella Ramos Escobedo
EFEliany León Figueredo
Eliany León Figueredo
Takotsubo cardiomyopathy (TCM), also known as stress-induced cardiomyopathy or "broken heart syndrome," is a transient left ventricular systolic dysfunction typically precipitated by emotional or physical stress. It closely mimics acute coronary syndrome (ACS) but occurs in the absence of significant coronary artery obstruction. We present the case of a 73-year-old woman with a medical history of hypertension, diabetes mellitus, hyperlipidemia, and osteoporosis, who presented with sudden-onset chest pain radiating to the throat, left arm, shoulder, and neck, accompanied by nausea, vomiting, and diaphoresis. Initial evaluation revealed elevated high-sensitivity troponin and B-type natriuretic peptide (BNP) levels, along with electrocardiographic findings suggestive of Wellens syndrome. Emergent coronary angiography demonstrated only minimal atherosclerotic disease. Left ventriculography revealed apical akinesis with basal hyperkinesis, consistent with TCM; an apical thrombus was also identified. The patient was managed with anticoagulation and supportive medical therapy. This case underscores the importance of considering TCM in elderly female patients presenting with ACS-like symptoms, particularly when coronary angiography does not reveal significant obstructive lesions.

15 December 2025 in Bionatura Journal
Verified
Journal Article
Open access
MGMarlon Carbonell Gonzalez
Marlon Carbonell Gonzalez
DRDeborah Cabrera Rodríguez
Deborah Cabrera Rodríguez
MAMaydelis Milo Alvarez
Maydelis Milo Alvarez
LWLyng Yon Wong
Lyng Yon Wong
LELhianella Ramos Escobedo
Lhianella Ramos Escobedo
RRRosali Santiago Roibal
Rosali Santiago Roibal
Cerebral edema is a severe neurological complication of preeclampsia and eclampsia, and continues to be a major contributor to maternal morbidity and mortality worldwide. Conventional methods for monitoring intracranial pressure (ICP) are invasive and unsuitable for obstetric patients, creating a need for a safe, non-invasive tool for early detection. In this prospective observational study, we evaluated the clinical utility of daily optic nerve sheath diameter (ONSD) monitoring using bedside ultrasonography in 50 women admitted to a tertiary ICU within 24 hours of symptom onset. Patients who developed eclampsia (n = 20) exhibited significantly higher mean ONSD values (5.66 ± 0.20 mm) compared with those with preeclampsia (4.61 ± 0.18 mm; p < 0.001). Notably, elevated ONSD consistently preceded overt neurological deterioration by 24–48 hours, showed a strong correlation with symptom severity (r = 0.76, p < 0.001), and was associated with longer ICU stays (7.8 ± 1.2 vs. 3.7 ± 0.8 days; p < 0.01). ROC curve analysis identified an optimal cutoff of 5.27 mm with 100% sensitivity and 100% specificity for detecting neuroimaging-confirmed cerebral edema. These findings indicate that daily ONSD measurement is a practical, reliable, and low-cost method for early identification of cerebral edema in hypertensive pregnancy disorders. By integrating ONSD into maternal ICU protocols, as summarized in our proposed monitoring algorithm, clinicians can anticipate neurological deterioration and implement timely interventions, particularly in settings where access to neuroimaging is limited. Beyond its immediate clinical value, this study underscores the potential role of ONSD monitoring in global maternal health strategies and highlights the need for multicenter trials to establish obstetric-specific cutoff values and validate its incorporation into international guidelines.